Temporal Trends in Antimicrobial Prescribing During Hospitalization for Potential Infection and Sepsis

Hallie C. Prescott, Sarah Seelye, Xiao Qing Wang, et al

JAMA Intern Med. Published online June 27, 2022. doi:10.1001/jamainternmed.2022.2291

Key Points

Question Is shortening the time to treatment for sepsis associated with increasing antimicrobial use, days of therapy, and broadness of coverage among the larger population of patients with potential infection?

Findings In this cohort study of 1 559 523 patients hospitalized at 152 hospitals in 2 health care delivery systems, the median time to first antimicrobial administration for sepsis decreased by 37 minutes from 2013 to 2018. During this same period, antimicrobial use, days of therapy, and broadness of antibacterial coverage declined among patients with potential infection.

Meaning These findings suggest that shortening the time to antibiotics administration for sepsis is feasible without leading to indiscriminate antimicrobial use, which can inform guidelines designed to accelerate early treatment for sepsis without having spillover effects onto other patients at risk for sepsis.

Abstract

Importance Some experts have cautioned that national and health system emphasis on rapid administration of antimicrobials for sepsis may increase overall antimicrobial use even among patients without sepsis.

Objective To assess whether temporal changes in antimicrobial timing for sepsis are associated with increasing antimicrobial use, days of therapy, or broadness of antimicrobial coverage among all hospitalized patients at risk for sepsis.

Design, Setting, and Participants This is an observational cohort study of hospitalized patients at 152 hospitals in 2 health care systems during 2013 to 2018, admitted via the emergency department with 2 or more systemic inflammatory response syndrome (SIRS) criteria. Data analysis was performed from June 10, 2021, to March 22, 2022.

Exposures Hospital-level temporal trends in time to first antimicrobial administration.

Outcomes Antimicrobial outcomes included antimicrobial use, days of therapy, and broadness of antibacterial coverage. Clinical outcomes included in-hospital mortality, 30-day mortality, length of hospitalization, and new multidrug-resistant (MDR) organism culture positivity.

Results Among 1 559 523 patients admitted to the hospital via the emergency department with 2 or more SIRS criteria (1 269 998 male patients [81.4%]; median [IQR] age, 67 [59-77] years), 273 255 (17.5%) met objective criteria for sepsis. In multivariable models adjusted for patient characteristics, the adjusted median (IQR) time to first antimicrobial administration to patients with sepsis decreased by 37 minutes, from 4.7 (4.1-5.3) hours in 2013 to 3.9 (3.6-4.4) hours in 2018, although the slope of decrease varied across hospitals. During the same period, antimicrobial use within 48 hours, days of antimicrobial therapy, and receipt of broad-spectrum coverage decreased among the broader cohort of patients with SIRS. In-hospital mortality, 30-day mortality, length of hospitalization, new MDR culture positivity, and new MDR blood culture positivity decreased over the study period among both patients with sepsis and those with SIRS. When examining hospital-specific trends, decreases in antimicrobial use, days of therapy, and broadness of antibacterial coverage for patients with SIRS did not differ by hospital antimicrobial timing trend for sepsis. Overall, there was no evidence that accelerating antimicrobial timing for sepsis was associated with increasing antimicrobial use or impaired antimicrobial stewardship.

Conclusions and Relevance In this multihospital cohort study, the time to first antimicrobial for sepsis decreased over time, but this trend was not associated with increasing antimicrobial use, days of therapy, or broadness of antimicrobial coverage among the broader population at-risk for sepsis, which suggests that shortening the time to antibiotics for sepsis is feasible without leading to indiscriminate antimicrobial use.